Parametric Portfolio Associates’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.49M Buy
45,505
+28,043
+161% +$832K ﹤0.01% 2574
2021
Q4
$460K Sell
17,462
-34,726
-67% -$2.69M ﹤0.01% 3109
2021
Q3
$5.25M Sell
52,188
-9,294
-15% -$1.09M ﹤0.01% 1793
2021
Q2
$8.7M Buy
61,482
+8,346
+16% +$942K ﹤0.01% 1488
2021
Q1
$5.3M Buy
53,136
+2,733
+5% +$319K ﹤0.01% 2124
2020
Q4
$6.23M Buy
50,403
+30,006
+147% +$3.94M ﹤0.01% 1925
2020
Q3
$1.99M Sell
20,397
-3,354
-14% -$419K ﹤0.01% 2509
2020
Q2
$3.71M Buy
23,751
+1,650
+7% +$251K ﹤0.01% 2093
2020
Q1
$3.19M Sell
22,101
-5,564
-20% -$1.07M ﹤0.01% 2065
2019
Q4
$5.66M Buy
27,665
+9,390
+51% +$1.71M ﹤0.01% 1968
2019
Q3
$1.47M Sell
18,275
-13,428
-42% -$1.14M ﹤0.01% 2818
2019
Q2
$2.99M Buy
31,703
+1,318
+4% +$114K ﹤0.01% 2385
2019
Q1
$2.6M Buy
30,385
+9,616
+46% +$798K ﹤0.01% 2492
2018
Q4
$1.17M Buy
20,769
+955
+5% +$58.3K ﹤0.01% 2888
2018
Q3
$1.62M Buy
+19,814
New +$1.4M ﹤0.01% 2846

Other funds holding RETA